As was discussed earlier, Ridky and colleagues have shown that GPER agonism can also heighten PD-L1 sensitivity in a preclinical model of pancreatic ductal adenocarcinoma [77]. This evidence concerns the gene GPER1 and pancreatic ductal adenocarcinoma.